FFCP PHASE2:Hg19::chr10:71892555..71892616,-
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p1@AIFM2 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_1_at_AIFM2_5end |
| Coexpression cluster: | NA |
| Association with transcript: | 0bp_to_ENST00000395039_5end |
| EntrezGene: | AIFM2 |
| HGNC: | 21411 |
| UniProt: | C9JI05 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p1@AIFM2 |
|---|
0
25
50
75
100
125
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| embryonic cell | 1.87e-13 | 250 |
| mesodermal cell | 8.92e-13 | 121 |
| epithelial cell | 1.65e-10 | 253 |
| fat cell | 6.32e-08 | 15 |
| muscle precursor cell | 2.38e-07 | 58 |
| myoblast | 2.38e-07 | 58 |
| multi-potent skeletal muscle stem cell | 2.38e-07 | 58 |
| muscle cell | 4.25e-07 | 55 |
| fibroblast | 4.31e-07 | 76 |
| mesothelial cell | 8.30e-07 | 19 |
Showing 1 to 10 of 10 entries
| Ontology term | p-value | n |
|---|---|---|
| trunk | 2.40e-17 | 199 |
| epithelial tube | 2.23e-15 | 117 |
| trunk mesenchyme | 3.03e-15 | 122 |
| mesenchyme | 5.50e-15 | 160 |
| entire embryonic mesenchyme | 5.50e-15 | 160 |
| unilaminar epithelium | 1.68e-12 | 148 |
| primordium | 5.19e-08 | 160 |
| endoderm-derived structure | 6.68e-08 | 160 |
| endoderm | 6.68e-08 | 160 |
| presumptive endoderm | 6.68e-08 | 160 |
Showing 1 to 10 of 35 entries
